Inflammation is a natural response to injury, infection, and stress. In the short term, inflammation helps the body heal. However, long-term inflammation can contribute to diseases like arthritis, heart disease, and diabetes.
Now, scientists have identified a natural mechanism that acts like an inflammation off switch. This system already exists in the body and helps regulate when inflammation should stop. However, it does not always function correctly. Researchers believe this discovery could lead to new treatments for chronic inflammatory diseases.
What Are the Findings?
Published in the journal Nature Communications, the study focused on a group of fat molecules called epoxy-oxylipins. These molecules help reduce inflammation when it becomes excessive or prolonged. Researchers found that epoxy-oxylipins can prevent the overproduction of immune cells that drive inflammation and disease.
To identify these molecules, scientists examined an enzyme pathway known as cytochrome P450. This pathway converts fatty acids into epoxy-oxylipins. Previous research suggested these molecules could reduce pain and inflammation. However, researchers still did not fully understand how they worked in humans.
To investigate further, researchers intentionally triggered inflammation in healthy volunteers. Participants received injections containing dead E. coli bacteria. The injections caused redness, heat, swelling, and discomfort. These symptoms closely resembled the body’s normal inflammatory response to injury or infection.
Researchers then administered a drug called GSK2256294. The drug protects epoxy-oxylipins by blocking an enzyme known as soluble epoxide hydrolase (sEH). Under normal conditions, sEH breaks down epoxy-oxylipins. By preventing this breakdown, researchers increased levels of the inflammation-regulating molecules.
To validate their findings, researchers divided participants into two groups. One group received the medication before inflammation began. The second group received the medication before symptoms appeared, a scenario that more closely reflects real-world treatment.
In both groups, treatment significantly increased levels of circulating epoxy-oxylipins. One molecule in particular, known as 12,13-EpOME, increased substantially. Participants also experienced improvements in pain and shorter-term inflammatory responses.
However, the treatment did not reduce visible signs of inflammation. Redness and swelling remained largely unchanged.
Many existing anti-inflammatory medications suppress broad portions of the immune system. While effective, this approach can leave people more vulnerable to infections and injury. In contrast, this newly identified pathway appears capable of limiting harmful inflammation while preserving normal immune function.
During the study, researchers discovered how the process works. They found that 12,13-EpOME interferes with a signaling pathway called p38 MAPK. This pathway normally promotes inflammation by encouraging monocytes to develop into more inflammatory immune cells.
By disrupting p38 MAPK signaling, researchers significantly reduced the buildup of inflammatory cells. This finding suggests that epoxy-oxylipins help control inflammation by changing how immune cells behave rather than broadly shutting down immune activity.
The study also revealed new information about a type of immune cell called intermediate monocytes. These cells are often associated with diseases such as rheumatoid arthritis, lupus, and obesity. Because they accumulate in many inflammatory conditions, researchers have traditionally viewed them as harmful.
However, the new findings suggest a more complicated role. In the short term, intermediate monocytes appear to help regulate immune responses. Researchers found that these cells support T cells, which play important roles in healing and immune system regulation.
Yet, when intermediate monocytes remain present for long periods, they may contribute to chronic inflammation and tissue damage. This discovery highlights how immune cells can be beneficial during healing but harmful when inflammatory responses persist.
The researchers believe their findings could eventually lead to new treatments for chronic inflammatory diseases. Rather than suppressing the immune system entirely, future therapies may help the body activate its own natural mechanisms for ending inflammation. Such treatments could provide relief from chronic inflammatory conditions while preserving the immune system’s ability to fight infections and promote healing.
Conclusion
Inflammation helps the body heal, but long-term inflammation can cause disease. Researchers discovered natural fat molecules that act like an inflammation off switch without weakening the immune system. Their findings could lead to safer treatments for chronic inflammatory conditions.
Have an upcoming trip? Passport Health offers a wide variety of options to help keep you safe from disease, including vaccines. Call or book online to schedule your appointment today.
Logan Hamilton is a health and wellness freelance writer for hire. He’s passionate about crafting crystal-clear, captivating, and credible content that elevates brands and establishes trust. When not writing, Logan can be found hiking, sticking his nose in bizarre books, or playing drums in a local rock band. Find him at loganjameshamilton.com.


Leave a Reply